The Effects of Maraviroc Versus Efavirenz in Combination With Zidovudine/Abacavir on the CD4/CD8 Ratio in Treatment-naive HIV-infected Individuals
Latest Information Update: 18 Sep 2023
At a glance
- Drugs Maraviroc (Primary) ; Efavirenz; Lamivudine/zidovudine
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms MeritRate
- 09 Oct 2017 Results (n=721) of post-hoc analysis of Merit study (NCT00098293, NCT03178084), published in the Antimicrobial Agents and Chemotherapy Journal.
- 08 Jun 2017 New trial record